Emergency department visits and hospitalizations for buprenorphine ingestion by children--United States, 2010-2011.
Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.
D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000506:poisoning*; D002047:Buprenorphine / Q000008:administration & dosage / Q000506:poisoning*; D002675:Child, Preschool; D004435:Eating; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007223:Infant; D014481:United States / Q000453:epidemiology
D000701:Analgesics, Opioid; D002047:Buprenorphine